The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wrighton-smith Peter since 2016.
The trader's CIK number is 1592286.
At the time of the last reporting, Wrighton-smith Peter was the Chief Executive Officer of Oxford Immunotec Global Plc. (stock ticker symbol OXFD).
Also see all insider trading activities at Oxford Immunotec Global Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | OXFD | 43,600 | $499,475 | 0 | $0 | 0 | $0 |
| 2019 | OXFD | 0 | $0 | 170,600 | $2,782,946 | 0 | $0 |
| 2018 | OXFD | 0 | $0 | 146,100 | $2,514,777 | 94,273 | $76,361 |
| 2017 | OXFD | 0 | $0 | 200,000 | $3,179,071 | 200,000 | $161,999 |
| 2016 | OXFD | 0 | $0 | 8,192 | $123,338 | 8,192 | $6,635 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-08 | OXFD | Buy | 2,075 | 10.75 | 22,306 |
| 2020-05-11 | OXFD | Buy | 26,000 | 11.45 | 297,700 |
| 2020-05-12 | OXFD | Buy | 15,525 | 11.56 | 179,469 |
| 2019-10-01 | OXFD | Sale | 30,000 | 16.21 | 486,390 |
| 2019-09-23 | OXFD | Sale | 20,000 | 14.92 | 298,360 |
| 2019-09-24 | OXFD | Sale | 80,000 | 17.01 | 1,361,120 |
| 2019-08-16 | OXFD | Sale | 10,000 | 13.87 | 138,650 |
| 2019-04-01 | OXFD | Sale | 10,600 | 16.93 | 179,426 |
| 2019-02-19 | OXFD | Sale | 10,000 | 16.99 | 169,930 |
| 2019-01-10 | OXFD | Sale | 10,000 | 14.91 | 149,070 |
| 2018-10-02 | OXFD | Sale | 10,000 | 16.93 | 169,259 |
| 2018-10-01 | OXFD | Sale | 10,000 | 16.50 | 165,000 |
| 2018-09-25 | OXFD | Option Ex | 54,273 | .81 | 43,961 |
| 2018-09-25 | OXFD | Sale | 86,100 | 18.38 | 1,582,518 |
| 2018-09-07 | OXFD | Option Ex | 40,000 | .81 | 32,400 |
| 2018-09-07 | OXFD | Sale | 40,000 | 14.95 | 598,000 |
| 2017-10-02 | OXFD | Option Ex | 55,000 | .81 | 44,550 |
| 2017-10-02 | OXFD | Sale | 55,000 | 16.78 | 922,954 |
| 2017-07-06 | OXFD | Option Ex | 27,168 | .81 | 22,006 |
| 2017-07-06 | OXFD | Sale | 27,168 | 15.94 | 433,003 |
| 2017-07-05 | OXFD | Sale | 32,832 | 16.58 | 544,420 |
| 2017-07-05 | OXFD | Option Ex | 32,832 | .81 | 26,593 |
| 2017-06-28 | OXFD | Option Ex | 30,000 | .81 | 24,300 |
| 2017-06-28 | OXFD | Sale | 30,000 | 16.06 | 481,799 |
| 2017-04-03 | OXFD | Option Ex | 30,000 | .81 | 24,300 |
| 2017-04-03 | OXFD | Sale | 30,000 | 15.43 | 463,020 |
| 2017-02-06 | OXFD | Option Ex | 25,000 | .81 | 20,250 |
| 2017-02-06 | OXFD | Sale | 25,000 | 13.36 | 333,875 |
| 2016-12-16 | OXFD | Option Ex | 7,052 | .81 | 5,712 |
| 2016-12-16 | OXFD | Sale | 7,052 | 15.06 | 106,238 |
| 2016-12-05 | OXFD | Option Ex | 1,140 | .81 | 923 |
| 2016-12-05 | OXFD | Sale | 1,140 | 15.00 | 17,100 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wrighton-smith Peter (Chief Executive Officer of Oxford Immunotec Global Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.